CA2115108A1 - Fil multifilament en polypropylene, et suture fabriquee avec ce fil - Google Patents

Fil multifilament en polypropylene, et suture fabriquee avec ce fil

Info

Publication number: CA2115108A1
Authority: CA; Canada
Prior art keywords: suture; denier; yarn; core; filaments
Prior art date: 1993-02-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002115108A

Other languages

English (en)

Inventor

Matthew E. Hain

Cheng-Kung Liu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

United States Surgical Corp

Original Assignee

United States Surgical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-09

Filing date

1994-02-07

Publication date

1994-08-10

1994-02-07 Application filed by United States Surgical Corp filed Critical United States Surgical Corp

1994-08-10 Publication of CA2115108A1 publication Critical patent/CA2115108A1/fr

Status Abandoned legal-status Critical Current

Links

-1 Polypropylene Polymers 0.000 title claims abstract description 61
239000004743 Polypropylene Substances 0.000 title claims abstract description 57
229920001155 polypropylene Polymers 0.000 title claims abstract description 57
238000010276 construction Methods 0.000 claims abstract description 33
238000002074 melt spinning Methods 0.000 claims abstract description 12
239000011347 resin Substances 0.000 claims description 9
229920005989 resin Polymers 0.000 claims description 9
239000000155 melt Substances 0.000 claims description 8
238000000034 method Methods 0.000 claims description 8
239000007787 solid Substances 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 description 9
239000000463 material Substances 0.000 description 8
102100021866 Hepatocyte growth factor Human genes 0.000 description 7
239000008358 core component Substances 0.000 description 7
230000001965 increasing effect Effects 0.000 description 5
238000000137 annealing Methods 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
206010052428 Wound Diseases 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
239000000306 component Substances 0.000 description 3
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
239000008199 coating composition Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000001125 extrusion Methods 0.000 description 2
239000000835 fiber Substances 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
238000009987 spinning Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
230000008467 tissue growth Effects 0.000 description 2
239000011800 void material Substances 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
230000037314 wound repair Effects 0.000 description 2
BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 1
208000031504 Asymptomatic Infections Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
102000002068 Glycopeptides Human genes 0.000 description 1
108010015899 Glycopeptides Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
108060003100 Magainin Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
102000019197 Superoxide Dismutase Human genes 0.000 description 1
108010012715 Superoxide dismutase Proteins 0.000 description 1
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
239000011149 active material Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000012830 laparoscopic surgical procedure Methods 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920002959 polymer blend Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
239000003356 suture material Substances 0.000 description 1
230000008733 trauma Effects 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

CA002115108A 1993-02-09 1994-02-07 Fil multifilament en polypropylene, et suture fabriquee avec ce fil Abandoned CA2115108A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1536893A	1993-02-09	1993-02-09
US08/015,368		1993-02-09

Publications (1)

Publication Number	Publication Date
CA2115108A1 true CA2115108A1 (fr)	1994-08-10

Family

ID=21770998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002115108A Abandoned CA2115108A1 (fr)	1993-02-09	1994-02-07	Fil multifilament en polypropylene, et suture fabriquee avec ce fil

Country Status (1)

Country	Link
CA (1)	CA2115108A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6264674B1 (en)	1998-11-09	2001-07-24	Robert L. Washington	Process for hot stretching braided ligatures

1994
- 1994-02-07 CA CA002115108A patent/CA2115108A1/fr not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6264674B1 (en)	1998-11-09	2001-07-24	Robert L. Washington	Process for hot stretching braided ligatures

Legal Events

Date	Code	Title	Description
2000-02-07	FZDE	Discontinued
2023-05-26	FZDE	Discontinued	Effective date: 20000207

Publication	Publication Date	Title
KR920002913B1 (ko)	1992-04-10	외과용 필라멘트
US5456697A (en)	1995-10-10	Cabled core and braided suture made therefrom
US5314446A (en)	1994-05-24	Sterilized heterogeneous braids
EP1690500B1 (fr)	2010-05-26	Suture à haute résistance
AU2015339573B2 (en)	2019-10-31	High strength small diameter fishing line
EP0523743B1 (fr)	1996-04-17	Toron stérilisé de fibres à deux composants
TW201428156A (zh)	2014-07-16	絞線
US9816211B2 (en)	2017-11-14	Optimized braid construction
US6174601B1 (en)	2001-01-16	Bicomponent fibers in a sheath-core structure comprising fluoropolymers and methods of making and using same
EA012987B1 (ru)	2010-02-26	Изделие для хирургического восстановления тканей
US6316103B1 (en)	2001-11-13	Bicomponent fibers in a sheath-core structure comprising fluoropolymers and methods of making and using same
CA2115108A1 (fr)	1994-08-10	Fil multifilament en polypropylene, et suture fabriquee avec ce fil
JP3576110B2 (ja)	2004-10-13	ロープ用長短複合紡績糸およびそれからなるロープ
CA2066246A1 (fr)	1992-06-06	Noyau cablee et suture tressee ainsi formee
GB2081585A (en)	1982-02-24	Surgical sutures
EP0759305A2 (fr)	1997-02-26	Suture tressée en polyester
JP4081338B2 (ja)	2008-04-23	ポリプロピレン系流体撹乱加工繊維及びその製造方法
RU2286409C2 (ru)	2006-10-27	Изделие с размерно стабильной полимерной многофиламентной пряжей (варианты) и способ формирования пряжи
CA1226099A (fr)	1987-08-25	Suture en copolymere d'ethylene-propylene
JPS599652B2 (ja)	1984-03-03	タイヤ補強織物用緯糸の製造法
JPH0518935B2 (fr)	1993-03-15
JP2001172820A (ja)	2001-06-26	ポリエステルマルチフィラメント
HK1122748B (en)	2013-07-05	Elongated surgical repair product based on ultra-high molar mass polyethylene filaments, the preparation thereof and ultra-high molar mass polyethylene filaments

CA2115108A1 - Fil multifilament en polypropylene, et suture fabriquee avec ce fil - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=21770998

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Similar Documents

Legal Events